Parkinsons Disease INFO CENTER

Statins are widely used medications that help people control cholesterol levels in the blood. Some research has shown these medications to have strong anti-inflammatory properties. Could these properties have an impact on the development of Parkinson's disease?

A doctor’s appointment without even leaving the house? Virtual house calls could be an important alternative for patients limited by distance or disability.

Tremors and shaking are well known symptoms of Parkinson’s disease. The lesser known non-motor symptoms like difficulty sleeping and digestive problems are not clearly defined in newly diagnosed patients.

There is currently no foolproof way to diagnose Parkinson’s disease (PD). Although a neurological exam and a review of the patient’s medical history can give a doctor insight to the possibility of PD, a test for the disease could save time and eliminate uncertainties.

Impulse control is not easy, especially for those with Parkinson’s disease. Recent research has suggested that excessive gambling, shopping, eating and sexuality are symptoms of the disease medication, not the disease itself.

Current available drugs for Parkinson’s disease (PD) treat symptoms and improve function but do not slow or halt the progression of the disease. A new drug recently tested in a clinical trial may be changing that.

As Parkinson’s disease (PD) progresses, symptoms like shaking and difficulty walking also progress. Those not in a position to get expensive or invasive treatments like deep brain stimulation may find relief through exercise.

Common knowledge says that exercise is good for the body and mind. How can exercise help people with mobility problems, like those living with Parkinson’s disease (PD)?

Past studies have suggested there is a link between Parkinson’s disease (PD) and cancer. A shared genetic predisposition is not only important for the patient, but also could have an affect on their relatives.

U.S. Food and Drug Administration officials have warned that a drug primarily used to treat symptoms associated with Parkinson's disease may increase the risk of heart failure.











